1. Home
  2. SINT vs BOLT Comparison

SINT vs BOLT Comparison

Compare SINT & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.35

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$5.20

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
BOLT
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
10.5M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
SINT
BOLT
Price
$2.35
$5.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$11.00
$34.00
AVG Volume (30 Days)
39.0K
20.7K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
N/A
EPS
N/A
N/A
Revenue
$1,018,000.00
$7,695,000.00
Revenue This Year
$30.26
N/A
Revenue Next Year
$413.20
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.07
52 Week Low
$1.99
$0.26
52 Week High
$6.78
$7.35

Technical Indicators

Market Signals
Indicator
SINT
BOLT
Relative Strength Index (RSI) 45.43 58.59
Support Level $2.28 $4.32
Resistance Level $2.98 $5.67
Average True Range (ATR) 0.15 0.35
MACD 0.01 0.04
Stochastic Oscillator 38.49 81.35

Price Performance

Historical Comparison
SINT
BOLT

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: